129 related articles for article (PubMed ID: 38240458)
1. Erianin inhibits tumor growth by promoting ferroptosis and inhibiting invasion in hepatocellular carcinoma through the JAK2/STAT3/SLC7A11 pathway.
Chen L; Sun R; Fang K
Pathol Int; 2024 Mar; 74(3):119-128. PubMed ID: 38240458
[TBL] [Abstract][Full Text] [Related]
2. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
Yang L; Hu Y; Zhou G; Chen Q; Song Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
[TBL] [Abstract][Full Text] [Related]
3. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis.
Chen P; Wu Q; Feng J; Yan L; Sun Y; Liu S; Xiang Y; Zhang M; Pan T; Chen X; Duan T; Zhai L; Zhai B; Wang W; Zhang R; Chen B; Han X; Li Y; Chen L; Liu Y; Huang X; Jin T; Zhang W; Luo H; Chen X; Li Y; Li Q; Li G; Zhang Q; Zhuo L; Yang Z; Tang H; Xie T; Ouyang X; Sui X
Signal Transduct Target Ther; 2020 May; 5(1):51. PubMed ID: 32382060
[TBL] [Abstract][Full Text] [Related]
4. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
5. Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis.
Dong H; Wang M; Chang C; Sun M; Yang F; Li L; Feng M; Zhang L; Li Q; Zhu Y; Qiao Y; Xie T; Chen J
Biochem Pharmacol; 2020 Dec; 182():114266. PubMed ID: 33035506
[TBL] [Abstract][Full Text] [Related]
6. Identification of Pyruvate Carboxylase as the Cellular Target of Natural Bibenzyls with Potent Anticancer Activity against Hepatocellular Carcinoma via Metabolic Reprogramming.
Sheng Y; Chen Y; Zeng Z; Wu W; Wang J; Ma Y; Lin Y; Zhang J; Huang Y; Li W; Zhu Q; Wei X; Li S; Wisanwattana W; Li F; Liu W; Suksamrarn A; Zhang G; Jiao W; Wang F
J Med Chem; 2022 Jan; 65(1):460-484. PubMed ID: 34931827
[TBL] [Abstract][Full Text] [Related]
7. Ethoxy-erianin phosphate and afatinib synergistically inhibit liver tumor growth and angiogenesis via regulating VEGF and EGFR signaling pathways.
Chen J; Liu J; Xu B; Cao Y; Liang X; Wu F; Shen X; Ma X; Liu J
Toxicol Appl Pharmacol; 2022 Mar; 438():115911. PubMed ID: 35143806
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone A Induces Ferroptosis in Hepatocellular Carcinoma via Reactive Oxygen Species Activated by the SLC7A11/GPX4 Pathway.
Zhang JX; Xiao Y; Li YQ; Zhu YL; Li YR; Zhao RS; Jin NY; Fang JB; Li X; Han JC
Integr Cancer Ther; 2023; 22():15347354231210867. PubMed ID: 37965730
[TBL] [Abstract][Full Text] [Related]
9. Saikosaponin A triggers cell ferroptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress-stimulated ATF3 expression.
Lan T; Wang W; Zeng XX; Tong YH; Mao ZJ; Wang SW
Biochem Biophys Res Commun; 2023 Sep; 674():10-18. PubMed ID: 37393639
[TBL] [Abstract][Full Text] [Related]
10. High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis.
Huang Q; Li J; Ma M; Lv M; Hu R; Sun J; Zhong X; Sun X; Feng W; Ma W; Zhang W; Zhan B; Han Z; Zhou X
Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36825585
[TBL] [Abstract][Full Text] [Related]
11. Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation.
Xiang Y; Chen X; Wang W; Zhai L; Sun X; Feng J; Duan T; Zhang M; Pan T; Yan L; Jin T; Gao Q; Wen C; Ma W; Liu W; Wang D; Wu Q; Xie T; Sui X
Front Pharmacol; 2021; 12():775506. PubMed ID: 34776986
[TBL] [Abstract][Full Text] [Related]
12. The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer.
Zhang X; Wang Y; Li X; Yang A; Li Z; Wang D
Aging (Albany NY); 2019 Nov; 11(22):10284-10300. PubMed ID: 31754081
[TBL] [Abstract][Full Text] [Related]
13. Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo.
Zhang HQ; Xie XF; Li GM; Chen JR; Li MT; Xu X; Xiong QY; Chen GR; Yin YP; Peng F; Chen Y; Peng C
Phytother Res; 2021 Aug; 35(8):4511-4525. PubMed ID: 34236105
[TBL] [Abstract][Full Text] [Related]
14. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD
Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265
[TBL] [Abstract][Full Text] [Related]
15. Erianin suppressed lung cancer stemness and chemotherapeutic sensitivity via triggering ferroptosis.
Lv J; Wang Z; Liu H
Environ Toxicol; 2024 Feb; 39(2):479-486. PubMed ID: 37209271
[TBL] [Abstract][Full Text] [Related]
16. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract][Full Text] [Related]
17. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
[TBL] [Abstract][Full Text] [Related]
18. TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
Li H; Lan H; Zhang M; Zhao F; An N; Yi C
Dig Dis Sci; 2023 Jul; 68(7):3070-3082. PubMed ID: 36680650
[TBL] [Abstract][Full Text] [Related]
19. Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma.
Li X; Li Y; Lian P; Lv Q; Liu F
Hum Exp Toxicol; 2023; 42():9603271221142818. PubMed ID: 36786348
[TBL] [Abstract][Full Text] [Related]
20. Iron Overload Induces Hepatic Ferroptosis and Insulin Resistance by Inhibiting the Jak2/stat3/slc7a11 Signaling Pathway.
Mo M; Pan L; Deng L; Liang M; Xia N; Liang Y
Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38801513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
